Tag: food-and-drug-administration

Picture Gallery Venture Capital

Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benefit in Phase 2b/3 Clinical Trial

March 28, 2017
Presse

LOS ANGELES, CA -- (Marketwired) -- 03/28/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR)Data Supports Further Clinical…

Continue Reading
Picture Gallery Venture Capital

Ritter Pharmaceuticals Appoints William Merino, Ph.D., to its Board of Directors

January 17, 2017
Presse

LOS ANGELES, CA -- (Marketwired) -- 01/17/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or…

Continue Reading